# Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

> **NCT06107920** · PHASE3 · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 232 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT06107920
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-07
- **Primary completion:** 2031-08
- **Final completion:** 2031-08
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107920, "Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06107920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*